Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04405115 · ClinicalTrials.gov registry record · NA

Improving Survivorship Care for Older Adults After Chemotherapy

A NA study of Survivorship, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04405115: Recruiting NA study of Survivorship, sponsored by University of California, San Francisco.

NCT04405115 is a NA study of Survivorship that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 228-participant average among 36 other Survivorship trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04405115, a NA study of Survivorship, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.

Primary Outcome

Feasibility of the study will be assessed by study retention rate which is defined as proportion of enrolled participants who remain enrolled until study completion.

Conditions Studied

Interventions

  • BEHAVIORAL Geriatric Assessment

Study Locations (1)

California

  • Community Cancer Institute - Clovis

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-02-16
Est. Completion 2026-05-30
Phase NA

What NCT04405115 shows while recruiting

NCT04405115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 228-participant average among 36 other Survivorship trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Survivorship appearing as the primary indexed condition, and to 1 intervention - of which Geriatric Assessment is the first listed.

NCT04405115 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04405115 about?

NCT04405115 is a clinical study titled "Improving Survivorship Care for Older Adults After Chemotherapy". The researchers want to find out if older adults receiving a survivorship care plan followed by a geriatric assessment visit improves quality of life and satisfaction with care compared to receiving only a survivorship care plan for older adults who have completed chemotherapy for cancer treatment.

What is the current status of trial NCT04405115?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-02-16. Estimated completion is 2026-05-30.

What conditions does trial NCT04405115 study?

This clinical trial studies the following conditions: Survivorship.

What interventions are being tested in trial NCT04405115?

The interventions under investigation include: Geriatric Assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04405115?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04405115 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04405115's enrollment target sits among peer trials

70 23rd of 36 higher than 13 of 36 other Survivorship trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04405115, the US trial registry maintained by the National Library of Medicine. NCT04405115 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.